Further processing options
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
Saved in:
Journal Title: | Oncology Reports |
---|---|
Authors and Corporations: | |
In: | Oncology Reports, 25, 2011, 3 |
Type of Resource: | E-Article |
Language: | English |
published: |
Spandidos Publications
|
Subjects: |